Session Details

S051 Vascular Anomalies Symposium: Classification, Clinical Challenges, and Management Update

Sun, Mar 10, 1:00 PM - 4:00 PM

Room 28D

3 CME Available Symposium

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

Dermatologists play a primary role in diagnosing and directing the management of vascular anomalies. Over the last decade there have been significant developments in the understanding of the pathogenesis of vascular anomalies which have impacted clinical practice, In this session, experts in the field will discuss key topics and literature relating to the evaluation and management of problematic infantile hemangiomas, capillary malformations and vascular anomalies.

LEARNING OBJECTIVES

Examine published data from last year on management of infantile hemangiomas and vascular anomalies

Develop tools for laser therapy and medical management of infantile hemangiomas and vascular anomalies

Enhance knowledge of diagnostic criteria and imaging of high risk infantile hemangiomas and vascular anomalies.

SCHEDULE

8:00 PM

Introduction

Dawn H. Siegel, MD, FAAD

8:05 PM

Infantile Hemangiomas in Preterm Infants

Ilona J. Frieden, MD, FAAD

8:25 PM

Hemangioma Hot Spots

Anita N Haggstrom, MD, FAAD

8:45 PM

Breaking News in PHACE and LUMBAR

Dawn H. Siegel, MD, FAAD, Denise W Metry, MD, FAAD

9:05 PM

Hot Topics in Hemangiomas

Sheilagh M. Maguiness, MD, FAAD

9:25 PM

Advances in medical therapies for vascular anomalies

Beth Ann Drolet, MD, FAAD

9:45 PM

Imaging guidelines for CM-AVM and Sturge-Weber

Eulalia Baselga Torres, MD, IFAAD

10:05 PM

Laser therapy for vascular anomalies

Erin F. Mathes, MD, FAAD

10:25 PM

Journals A Year in Review- JOVA and Beyond

Maria Cecilia Garzon, MD, FAAD

10:45 PM

Challenging cases panel discussion

SPEAKERS

Eulalia Baselga Torres, MD, IFAAD

Beth Ann Drolet, MD, FAAD

Ilona J. Frieden, MD, FAAD

Maria Cecilia Garzon, MD, FAAD

Anita N Haggstrom, MD, FAAD

Sheilagh M. Maguiness, MD, FAAD

Erin F. Mathes, MD, FAAD

Denise W Metry, MD, FAAD

Dawn H. Siegel, MD, FAAD

HANDOUTS

SPEAKER DISCLOSURES

Eulalia Baselga Torres, MD, IFAAD

AbbVie – Investigator(Fees); Almirall – Speaker(Honoraria); Cytovation – Consultant(Fees); Demira – Investigator(Fees); Ferrer – Consultant(Honoraria), Speaker(Fees); Isdin – Speaker/Faculty Education(Honoraria); Martiderm – Speaker(Fees); Novartis – Other(Other Financial Benefit), Speaker(Fees); Pierre Fabre Dermatologie – Investigator(Honoraria), Speaker(Fees); Sanofi/Regeneron – Consultant(Fees); venthera – Founder(Stock Options);

Beth Ann Drolet, MD, FAAD

Arkayli Biosciences – Founder(Stock); Novartis Pharmaceuticals Corp. – Investigator(No Compensation Received); Peds Derm Research LLC – Founder(Stock); Pierre Fabre Dermatologie – Other(Grants/Research Funding); Venthera – Consultant(Fees);

Ilona J. Frieden, MD, FAAD

Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Data Safety Monitoring Board(Fees); Verrica Pharmaceuticals Inc – Advisory Board(Honoraria);